ResMed Appoints Michael Farrell as Chief Executive Officer; Robert Douglas Appointed President and Chief Operating Officer
|
ResMed Inc. (NYSE: RMD) announced that effective March 1, 2013, Michael ("Mick") Farrell will succeed Dr. Peter C. Farrell as ResMed's chief executive officer (CEO) and be appointed to its board of directors. Robert ("Rob") Douglas will become ResMed's president and chief operating officer (COO). Current CEO, chairman of the board and founder, Dr. |
Study Shows the Value of Sleep Specialists in Promoting CPAP Adherence
|
A new study reports that a consultation with a board certified sleep medicine physician prior to undergoing a diagnostic PSG is predictive of increased 30-day CPAP use. The study appears in the March 15 issue of the Journal of Clinical Sleep Medicine. |
Penn Study Finds Increased Sleep Could Reduce Rate of Adolescent Obesity
|
Results show each additional hour of sleep is associated with a lower BMI for teens |
Study Links Diabetes Risk to Melatonin Levels
|
Low nocturnal melatonin secretion levels are associated with an increased risk of developing type 2 diabetes |
